期刊文献+

冠心病患者血浆IL-35水平的变化及意义 被引量:7

原文传递
导出
摘要 冠状动脉粥样硬化性心脏病(coronaryathero.scleroticheartdisease,CHD)是动脉粥样硬化(athero.sclerosis,AS)性疾病中最常见也是最严重的类型。AS是一种慢性炎症性疾病,往往表现为促炎相关因子活性升高和抗炎细胞与因子活性下降。
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2013年第7期759-760,764,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(81160045)
  • 相关文献

参考文献13

  • 1Ross R. Atherosclerosis is an inflammatory disease[ J]. Am Heart J,1999, 138(5Pa): S419-420.
  • 2Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokineIL-35 contributes to regulatory T-cell function [ J ]. Nature, 2007,450?7169): 566 -569.
  • 3Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T-cell immunity inatherosclerosis[ J] . Trends Cardiovasc Med,2007 , 17(4): 113 -118.
  • 4Eid RE, Rao DA, Zhou J, et al. Interleukin-17 and interferon-gammaare produced concomitantly by human coronary artery-infiltrating Tcells and act synergistically on vascular smooth muscle cells [ J ].Circulation, 2009, 119(10) : 1424-1432.
  • 5Cheng X, Yu X, Ding YJ,et al. The Thl7/Treg imbalance inpatients with acute coronary syndrome [ J]. Clin Immunol,2008,127(1) : 89 -97.
  • 6Kempe S, Heinz P, Kokai E, et al. Epstein-barr virus-inducedgene-3 is expressed in human atheroma plaques [ J ]. Am J Pathol,2009, 175(1) : 440-447.
  • 7Chaturvedi V, Collison LW, Guy CS, et al. Cutting edge: Humanregulatory T cells require IL-35 to mediate suppression and infectioustolerance[ J]. J Immunol, 2011, 186(12) : 6661 -6666.
  • 8Niedbala W, Wei XQ, Cai B, et al. IL-35 is a novel cytokine withtherapeutic effects against collagen-induced arthritis through theexpansion of regulatory T cells and suppression of Thl7 cells [ J ].Eur J Immunol, 2007, 37(11) ; 3021 -3029.
  • 9Kochetkova I,Golden S, Holdemess K, et al. IL-35 Stimulation ofGD39 + regulatory T cells confers protection against collagen H -induced arthritis via the production of IL-10[ J]. J Immunol,2010,184(12): 7144-7153.
  • 10Castellani ML, Anogeianaki A, Felaco P, et al. IL-35, ananti -inflammatory cytokine which expands CD4 + CD25 + Treg cells[J]. J Biol Regul Homeost Agents, 2010, 24(2) : 131 - 135.

同被引文献107

  • 1胡强.尼可地尔在冠心病治疗中的临床进展[J].世界临床医学,2017,11(1):110-110. 被引量:1
  • 2杨红霞.老年冠心病患者临床特点及治疗[J].今日健康,2016,15(1):117-117. 被引量:1
  • 3熊杰,白生华,徐万清,古宇,龚杨彬,刘华伟.血清同型半胱氨酸与冠心病的相关性研究[J].中国分子心脏病学杂志,2010,10(6):326-327. 被引量:8
  • 4无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2187
  • 5Persson J,Nilsson J,Lindholm MW. Interleukin-lbeta and tumour necrosis factor-alpha impede neutral lipid turn over in macrophage- derived foam cells[J].BMC Immunology,2008,9:70.
  • 6Stegger JG,Schmidt EB,Tjonneland A,et al. Single Nucleotide Polymorphisms in IL1B and the Risk of Acute Coronary Syndrome: A Danish Case-Cohort Study[J]. PLoS One,2012,7(6):e36829.
  • 7Ait-Oufella H,Taleb S,Mlalat Z,et al. Recent advnaces on the role of eytokinse in atherosclerosi s[J]. Arterieseler Thromb Vsoc Biol,2011,31 (5):969-79.
  • 8Jenny NS,Brown ER,Detrano R,et al. Associations of inflammatory markers with coronary artery calcification: results from the Multi- Ethnic Study of Atherosclerosis[J]. Atherosclerosis,2010,209 (1):226-9.
  • 9Tretjakovs P,Jurka A,Bormane I,et al. Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients[J]. Eur J Internal Med,2009,20(7):712-7.
  • 10Ridker PM,Rifai N,Stampfer MJ,et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthymen[J]. Circulation,2000,101 ( 15): 1767 -72.

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部